B-READY: University of North Carolina-Healthwise Partnership Project on Birth Options Decision Aid

Sponsor
University of North Carolina, Chapel Hill (Other)
Overall Status
Completed
CT.gov ID
NCT04053413
Collaborator
Healthwise (Other)
100
1
2
20.5
4.9

Study Details

Study Description

Brief Summary

This is pilot quasi-experimental study of women with one or two prior cesarean deliveries who are now pregnant and eligible for a trial of labor after cesarean delivery, to assess whether a decision aid, providing knowledge about trial of labor (VBAC) and planned repeat cesarean delivery can improve the birth options decision-making process for patients.

Participants are screened for eligibility through electronic health records. Once an individual is screened eligible, and email invite is sent providing information about the study and assessing the interest in participation. An on-line consent is completed and women are entered sequentially into the usual care group and then through further recruitment, another sample of women are entered into the decision aid group. The primary outcome is satisfaction with the shared decision-making process with their provider.

Condition or Disease Intervention/Treatment Phase
  • Other: Decision Aid
N/A

Detailed Description

Once a potential participant is screened eligible, completes the on-line informed consent, they are officially enrolled in the study and sent a link confirming their enrollment and the study group in which they have been assigned. Participants are sequentially enrolled in the study with enrollment first into the usual care group. Once enrollment in the usual care group is complete, enrollment into the decision aid group will occur.

The study includes two non-randomized groups:

Arm 1 (Usual care group): Women in this group will undergo usual care and complete the survey questions on knowledge of risks and benefits of TOLAC (also referred to as VBAC) and planned repeat cesarean (PRCS), certainty of their decision, and involvement in the decision for trial of labor (TOLAC) or repeat cesarean delivery.

Arm 2: (Decision aid group- group receiving the decision tool): Women in this group will receive a decision aid prior to undergoing counseling by their physician. Following completion of the decision aid and physician counseling, they will complete a series of survey questions to assess their knowledge of the risks and benefits of TOLAC and PRCS, certainty of their decision, and involvement in the decision for repeat cesarean or TOLAC.

The decision aid group will be compared with women who do not receive the decision aid (usual care group).

Study Design

Study Type:
Interventional
Actual Enrollment :
100 participants
Allocation:
Non-Randomized
Intervention Model:
Sequential Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Pilot Study to Assess the Effectiveness of a Decision Tool for Cesarean Delivery vs. Trial of Labor
Actual Study Start Date :
Apr 16, 2018
Actual Primary Completion Date :
Jul 31, 2019
Actual Study Completion Date :
Dec 31, 2019

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Usual care

Women in this group will undergo usual care and the complete the survey questions on knowledge and involvement in the decision for trial of labor after cesarean (TOLAC) or repeat cesarean.

Active Comparator: Decision Aid

Women in this group will receive a decision aid prior to undergoing counseling by their physician. Following completion of the decision aid and physician counseling, they will complete a series of survey questions to assess their perceptions of their knowledge and involvement in the decision for trial of labor after cesarean (TOLAC) or repeat cesarean delivery.

Other: Decision Aid
The decision aid is a series of web pages that includes videos, questions, and evidence-based information. The decision aid is designed to help women think about what matters to them and what questions they may have for their doctor or midwife. At the end, they receive a summary of which way they are leaning and what matters most to them.

Outcome Measures

Primary Outcome Measures

  1. Shared Decision Making (SDM) Process score [Up to 6 months prior to delivery]

    This is a measure of the patient's involvement in the decision. 1 point is assigned for discussing the pros 'a lot' or 'some'; 1 point is assigned for discussing the cons 'a lot' or 'some'; 1 point is assigned for responding 'yes' if the provider explained the options; and 1 point is assigned for responding 'yes' that the provider asked the patient what treatment she wanted. The tool's score range is 0-4. A higher score indicates more involvement in the decision.

Secondary Outcome Measures

  1. Number of Participants (by category) With the Intent to Deliver by Repeat Cesarean Section or by Vaginal Delivery [Date of Admission]

    Intended mode of delivery (repeat cesarean or vaginal) prior to actual delivery

  2. Number of Participants (by category) who Delivered by Repeat Cesarean or Vaginal Delivery [Up to 72 hours after delivery]

    Actual method of delivery (repeat cesarean or vaginal delivery)

  3. Maternal or Fetal Complications at Delivery [Up to 72 hours after delivery]

    Number of complication events: maternal postpartum hemorrhage, infection, fetal admission to neonatal intensive care unit.

  4. Number of Participants (by Category) who desired Repeat Cesarean, Vaginal Delivery or Are Undecided after completion of the study survey [Up to 6 months prior to delivery]

    Participant responses are: 1) repeat cesarean delivery, 2) vaginal delivery and 3) undecided

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Gestational age between 19/0 and 36/6 weeks

  • History of 1 or 2 prior cesarean deliveries

Exclusion Criteria:
  • No contraindications to trial of labor after cesarean (TOLAC)

  • No history of prior TOLAC

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of North Carolina - Chapel Hill Chapel Hill North Carolina United States 27517

Sponsors and Collaborators

  • University of North Carolina, Chapel Hill
  • Healthwise

Investigators

  • Principal Investigator: Wanda K Nicholson, MD, Univerisity of North Carolina - Chapel Hill

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of North Carolina, Chapel Hill
ClinicalTrials.gov Identifier:
NCT04053413
Other Study ID Numbers:
  • 17-2023
First Posted:
Aug 12, 2019
Last Update Posted:
Jan 21, 2020
Last Verified:
Jan 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jan 21, 2020